Valeant Pharmaceuticals reported $1.05B in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4411M 325M
Ani Pharmaceuticals ANIP:US $ 83.16M 1.46M
Aurora Cannabis Inc ACB:CN 129.9M 19.63M
Biogen BIIB:US $ 1215.4M 136.1M
Bristol Myers Squibb BMY:US $ 2104M 9M
Canopy Growth Corp WEED:CN C$ 204.39M 161.36M
Catalent CTLT:US $ 697M 9M
Corcept Therapeutics CORT:US $ 5.08M 0.09M
Danaher DHR:US $ 3072M 305M
Eli Lilly And LLY:US $ 3893M 7M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
Gilead Sciences GILD:US $ 2675M 1057M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Lannett LCI:US $ 95.43M 10.34M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Perrigo Ordinary Shares PRGO:US $ 1022.4M 2.2M
Phibro Animal Health PAHC:US $ 249.91M 19.13M
Prestige Brands PBH:US $ 120.34M 14.07M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Valeant Pharmaceuticals VRX:CN $ 1045M 52M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M
Zoetis ZTS:US $ 2057M 134M